C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2001
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2000053731A3 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010046968 Angiogenesis inhibition; especially administering naltrexone, naloxone, antibody against OGF or OGF receptor, or antisense molecule of OGF- receptor-encoding gene
11/29/2001	US20010046697 Bacillus natto culture extract
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2412306A1 Human sodium channel scn12a and scn8a
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001	CA2409991A1 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408302A1 Long wavelength engineered fluorescent proteins
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158048A1 Photoprotein derived from Okinawan squid and gene encoding the photoprotein
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157125A1 Monkey gonadotropin releasing hormone receptor
11/28/2001	EP1157118A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
11/28/2001	EP1157109A2 14273 receptor, a g-protein coupled receptor
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157034A1 Process for production of diphtheria toxin
11/28/2001	EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
11/28/2001	EP1156819A1 Methods and compositions for modulating fertility
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0783520B1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
11/28/2001	EP0628075B1 Endo-1,4-beta-d-glucanase
11/28/2001	EP0460190B2 Method for detecting malignant diseases
11/28/2001	CN1324407A Plant-optimized polynucleotides encoding approximately 15 KDa and approximately 45 KDa pesticidal proteins
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324258A Aglyco products and method of use
11/28/2001	CN1324247A Process and materials for the repid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324214A Utilization of an antifungal protein fron streptomyces tendae against plant pathogenic fungi
11/28/2001	CN1323887A Scallion and litus agglutinin protein and its encoding sequence
11/28/2001	CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001	CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/27/2001	US6323323 Ligand-binding, dimerized polypeptide fusions
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001	US6323178 Beta-lipotropin methods
11/27/2001	US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
11/27/2001	US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome
11/27/2001	US6323004 Modulation of polypeptide display on modified filamentous phage
11/27/2001	US6323002 Methods for modifying the production of a polypeptide
11/27/2001	US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001	US6322997 Protein recovery
11/27/2001	US6322996 Reacting a physiologically active protein with an amino group donor or alkylamine-containing polysaccharide in presence of transglutaminase, thereby modifying protein by forming an amido linkage between carboxyamide group of glutamine residue
11/27/2001	US6322967 Recombinant tryptophan mutants of influenza
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
11/27/2001	US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001	US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure
11/27/2001	CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
11/27/2001	CA2145866C Human calcitonin receptor
11/27/2001	CA2074837C Methods of producing hybrid g protein-coupled receptors
11/27/2001	CA2063511C Method for producing human serum albumin
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/22/2001	WO2001088190A2 Poly-primed amplification of nucleic acid sequences
11/22/2001	WO2001088175A1 Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase
11/22/2001	WO2001088143A1 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088117A2 In vitro fucosylation recombinant glycopeptides
11/22/2001	WO2001088100A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
11/22/2001	WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087931A2 Bacterial insecticidal proteins
11/22/2001	WO2001087925A2 Methods for refolding proteins containing free cysteine residues
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087058A1 Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells

1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 1125